Refer A Friend

Contact Us

Upcoming

Oral GLP Weight Loss

W8M-MC-OG01
Oral daily weight loss medication (triple agonist: GLP/GIP/Glucagon) for overweight/obese patients without diabetes.
Status: 
Upcoming
Compensation: 
$4564
Location: Greenville - 545 Verdae Blvd., Lower Level, Suite B
Number of Visits: 
Discussed at screening
Age Group: 
18-75
Qualifications: 
BMI ≥ 30 or a BMI of ≥ 27 with an additional weight related diagnosis, e.g. high blood pressure, high cholesterol, sleep apnea, MASH, or heart disease. | Must not have taken a GLP or weight-lowering medications within the last 6 months.
Location(s):
Greenville - 545 Verdae Blvd., Lower Level, Suite B
*You may receive compensation for your time and completed study visits.

Other Popular Trials

Get in Touch
Phone: 864.334.0141
Fax: 864.334.0137
Join Our Email List
Stay informed about our clinical trials and 
community events.*
Sign Me Up
*By submitting this form, you agree to receive email 
notifications from us. You can unsubscribe at any time.
Follow Us:
©2026 Tribe Clinical Research
All Rights Reserved